Seres Therapeutics Inc
NASDAQ:MCRB

Watchlist Manager
Seres Therapeutics Inc Logo
Seres Therapeutics Inc
NASDAQ:MCRB
Watchlist
Price: 7.5 USD Market Closed
Market Cap: 65.5m USD

Wall Street
Price Targets

MCRB Price Targets Summary
Seres Therapeutics Inc

There are no price targets for MCRB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Seres Therapeutics Inc Competitors:
Price Targets
300601
Shenzhen Kangtai Biological Products Co Ltd
20% Upside
DBV
DBV Technologies SA
140% Upside
ABBV
Abbvie Inc
14% Upside
IMTX
Immatics NV
137% Upside
TRDA
Entrada Therapeutics Inc
226% Upside
TLX
Telix Pharmaceuticals Ltd
34% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
38% Upside
VYGR
Voyager Therapeutics Inc
394% Upside

Revenue
Forecast

Revenue Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Seres Therapeutics Inc

The compound annual growth rate of Seres Therapeutics Inc's net income for the next 3 years is 215%.

N/A
Past Growth
215%
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MCRB's stock price target?
Not Available

MCRB doesn't have any price targets made by Wall Street professionals.

What is Seres Therapeutics Inc's Net Income forecast?
Projected CAGR
215%

The compound annual growth rate of Seres Therapeutics Inc's net income for the next 3 years is 215%.

Back to Top